Isaac S Alderete, Qimeng Gao, Nihal Aykun, Mohamed Mustafa Diab, Nader Abraham, Siavash Raigani, Brian Shaw, Aparna Rege, Lisa McElroy, Deepak Vikraman, Kadiyala Ravindra, Bradley H Collins, Stuart J Knechtle, Debra L Sudan, Andrew S Barbas
{"title":"Back-to-base Versus In-transit Machine Perfusion in Donation After Circulatory Death Liver Transplantation: Insights From a National Registry.","authors":"Isaac S Alderete, Qimeng Gao, Nihal Aykun, Mohamed Mustafa Diab, Nader Abraham, Siavash Raigani, Brian Shaw, Aparna Rege, Lisa McElroy, Deepak Vikraman, Kadiyala Ravindra, Bradley H Collins, Stuart J Knechtle, Debra L Sudan, Andrew S Barbas","doi":"10.1097/TXD.0000000000001925","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Normothermic machine perfusion (NMP) improves utilization of extended criteria liver grafts, but the optimal delivery strategy-whether in-transit or back-to-base-remains uncertain.</p><p><strong>Methods: </strong>Adult recipients of donation after circulatory death (DCD) liver transplants between January 1, 2022, and January 1, 2024, were identified using the national transplant database. In-transit NMP was defined as grafts coded as machine perfused; back-to-base NMP was inferred for noncoded grafts with a cold ischemia time of ≥10 h. Baseline characteristics, geographic distribution, and outcomes-including acute rejection, length of stay, and graft survival-were compared. Multivariable Cox regression was used to adjust for dialysis and recipient hospitalization status. A sensitivity analysis was performed, limited to cases with cold ischemia time of ≥10 h across both groups.</p><p><strong>Results: </strong>Among 1217 DCD liver transplants using NMP, 936 (77%) were in-transit and 281 (23%) were back-to-base. In-transit NMP was more commonly used in the Western United States, whereas back-to-base was concentrated in the Midwest and Southeast. In-transit recipients had higher rates of pretransplant dialysis (3.1% versus 0.7%; <i>P</i> < 0.05) and shorter preservation times (14.1 versus 16.0 h; <i>P</i> < 0.05). Median hospital stay was shorter in the in-transit group (8 versus 9 d, <i>P</i> < 0.001). There were no significant differences in acute rejection (<i>P</i> = 0.15) or 1-y graft survival (93.3% versus 90.5%, <i>P</i> = 0.23). In adjusted analysis, back-to-base NMP was not associated with increased graft failure risk (hazard ratio 1.46; 95% confidence interval, 0.90-2.38; <i>P</i> = 0.13). Findings were consistent in the sensitivity analysis (n = 1001).</p><p><strong>Conclusions: </strong>In-transit and back-to-base NMP strategies yield comparable clinical outcomes in DCD liver transplantation. Strategy selection may be guided by logistical infrastructure and center-level expertise without compromising recipient outcomes.</p>","PeriodicalId":23225,"journal":{"name":"Transplantation Direct","volume":"12 4","pages":"e1925"},"PeriodicalIF":2.2000,"publicationDate":"2026-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12962566/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation Direct","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/TXD.0000000000001925","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"TRANSPLANTATION","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Normothermic machine perfusion (NMP) improves utilization of extended criteria liver grafts, but the optimal delivery strategy-whether in-transit or back-to-base-remains uncertain.
Methods: Adult recipients of donation after circulatory death (DCD) liver transplants between January 1, 2022, and January 1, 2024, were identified using the national transplant database. In-transit NMP was defined as grafts coded as machine perfused; back-to-base NMP was inferred for noncoded grafts with a cold ischemia time of ≥10 h. Baseline characteristics, geographic distribution, and outcomes-including acute rejection, length of stay, and graft survival-were compared. Multivariable Cox regression was used to adjust for dialysis and recipient hospitalization status. A sensitivity analysis was performed, limited to cases with cold ischemia time of ≥10 h across both groups.
Results: Among 1217 DCD liver transplants using NMP, 936 (77%) were in-transit and 281 (23%) were back-to-base. In-transit NMP was more commonly used in the Western United States, whereas back-to-base was concentrated in the Midwest and Southeast. In-transit recipients had higher rates of pretransplant dialysis (3.1% versus 0.7%; P < 0.05) and shorter preservation times (14.1 versus 16.0 h; P < 0.05). Median hospital stay was shorter in the in-transit group (8 versus 9 d, P < 0.001). There were no significant differences in acute rejection (P = 0.15) or 1-y graft survival (93.3% versus 90.5%, P = 0.23). In adjusted analysis, back-to-base NMP was not associated with increased graft failure risk (hazard ratio 1.46; 95% confidence interval, 0.90-2.38; P = 0.13). Findings were consistent in the sensitivity analysis (n = 1001).
Conclusions: In-transit and back-to-base NMP strategies yield comparable clinical outcomes in DCD liver transplantation. Strategy selection may be guided by logistical infrastructure and center-level expertise without compromising recipient outcomes.